![Jean Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean Kim
Nessuna posizione attualmente
Profilo
Jean J.
Kim worked as Principal at Merrill Lynch Ventures LLC in 2006.
From 2006 to 2020, served as Partner at Deerfield Management Co. LP.
Held the position of Director at Amplo Biotechnology, Inc. from 2021 to 2023.
Served as Independent Director at Avidity Biosciences, Inc. from 2021 to 2026.
Education includes undergraduate studies at Stanford University, a graduate degree from Massachusetts Institute of Technology conferred in 2006, and an MBA from Harvard Business School.
Precedenti posizioni note di Jean Kim
| Società | Posizione | Fine |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 27/02/2026 |
Amplo Biotechnology, Inc.
 Amplo Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direttore/Membro del Consiglio | 01/12/2023 |
Deerfield Management Co. LP
 Deerfield Management Co. LP Investment ManagersFinance Deerfield conducts extensive fundamental research into healthcare sector assets and investment opportunities. The firm makes use of this fundamental research to identify investment opportunities, determine how best to structure or “express” an investment thesis, direct the purchase and sale of securities, negotiate structured investment transactions, and generally manage and invest the assets of the Funds. The majority of Fund investments are made in companies that are organized in the United States or that issue securities available in the US public securities markets. | Analyst-Equity | 01/07/2020 |
Merrill Lynch Ventures LLC
 Merrill Lynch Ventures LLC Investment ManagersFinance Merrill Lynch Ventures invests in companies located in the United States. The firm focuses across a broad range of sectors and industries. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01/01/2006 |
Formazione di Jean Kim
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Deerfield Management Co. LP
Deerfield Management Co. LP Investment ManagersFinance Deerfield conducts extensive fundamental research into healthcare sector assets and investment opportunities. The firm makes use of this fundamental research to identify investment opportunities, determine how best to structure or “express” an investment thesis, direct the purchase and sale of securities, negotiate structured investment transactions, and generally manage and invest the assets of the Funds. The majority of Fund investments are made in companies that are organized in the United States or that issue securities available in the US public securities markets. | Finance |
Merrill Lynch Ventures LLC
Merrill Lynch Ventures LLC Investment ManagersFinance Merrill Lynch Ventures invests in companies located in the United States. The firm focuses across a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amplo Biotechnology, Inc.
Amplo Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
